Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 7001 - 7025 of 7769 in total

Beta-Amino Isobutyrate

Experimental

(5Z)-3-(4-CHLOROPHENYL)-4-HYDROXY-5-(1-NAPHTHYLMETHYLENE)FURAN-2(5H)-ONE

Experimental

CPG-52852

852A has been used in trials studying the treatment of Melanoma, Neoplasms, Breast Cancer, Ovarian Cancer, and Cervical Cancer, among others.
Investigational

N-methyl-{4-[2-(7-oxo-6,7-dihydro-8H-[1,3]thiazolo[5,4-e]indol-8-ylidene)hydrazino]phenyl}methanesulfonamide

Experimental

Mavoglurant

Mavoglurant has been used in trials studying the treatment of Patient Diagnosed With OCD and and Resistant to SSRI Treatment (Failed SSRI Over 12 Weeks at Appropriate Doses).
Investigational

Propenidazole

Experimental

4-(5-Bromo-2-Oxo-2h-Indol-3-Ylazo)-Benzenesulfonamide

Experimental

Saccharin

Saccharin has been investigated for the treatment of Hypertension and Hyperglycemia.
Investigational

Solithromycin

Solithromycin is a ketolide antibiotic undergoing clinical development for the treatment of community-acquired pneumonia (CAP) and other infections.
Investigational

CRA_16847

Experimental

5-Bromo-N-[(2S)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide

Experimental

2-[(2-chloro-4-iodophenyl)amino]-N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluorobenzamide

Experimental

4-(5-BENZENESULFONYLAMINO-1-METHYL-1H-BENZOIMIDAZOL-2-YLMETHYL)-BENZAMIDINE

Experimental

3-(4-Amino-2-Tert-Butyl-5-Methyl-Phenylsulfanyl)-6-Cyclopentyl-4-Hydroxy-6-[2-(4-Hydroxy-Phenyl)-Ethyl]-5,6-Dihydro-Pyran-2-One

Experimental

Voacamine

Voacamine is an alkaloid isolated from the bark of the Pescheria fuchsiae folia tree. It is an antimalarial drug approved for use in several African countries. Voacamine is also under investigation for use in modulating multidrug-resistance in tumor cells.
Experimental

Brecanavir

Brecanavir (VX-385) an orally active aspartic protease inhibitor (PI), under investigation by Vertex and GlaxoSmithKline for the treatment of HIV. In July 2006, Vertex indicated that it expected GSK to initiate phase III trials of the drug in 2007. In December of 2006 GSK announced a decision to discontinue the...
Investigational

Altropane

Boston Life Sciences (BLS) is developing Altropane as a potential radio-imaging agent to be used with single photon emission tomography (SPECT), for the early diagnosis of Parkinson's disease (PD) and attention deficit hyperactivity disorder (ADHD).
Investigational

2-[(4-fluorophenyl)sulfonylamino]-N-oxo-ethanamide

Experimental

(R)-carnitinyl-CoA betaine

Experimental

Quisinostat

Quisinostat has been used in trials studying the treatment of Lymphoma, Neoplasms, Myelodysplastic Syndromes, and Advanced or Refractory Leukemia.
Investigational

N-Butyl-Benzenesulfonamide

Experimental

5-Mercaptoethanol-2-decenoyl-coenzyme A

Experimental

indane-5-sulfonamide

Experimental

N-(6-Aminohexyl)-5-Chloro-1-Naphthalenesulfonamide

Experimental

CH-5132799

CH5132799 has been used in trials studying the treatment of Solid Tumors.
Investigational
Displaying drugs 7001 - 7025 of 7769 in total